EIVFX
Price
$13.32
Change
-$0.16 (-1.19%)
Updated
Feb 21 closing price
Net Assets
1.35B
RMEBX
Price
$57.54
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

EIVFX vs RMEBX

Header iconEIVFX vs RMEBX Comparison
Open Charts EIVFX vs RMEBXBanner chart's image
Allspring Special Large Cap Value R6
Price$13.32
Change-$0.16 (-1.19%)
VolumeN/A
Net Assets1.35B
American Funds American Mutual R2E
Price$57.54
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
EIVFX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EIVFX vs. RMEBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIVFX is a Hold and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. EIVFX (1.35B). RMEBX pays higher dividends than EIVFX: RMEBX (1.54) vs EIVFX (1.05). EIVFX was incepted earlier than RMEBX: EIVFX (12 years) vs RMEBX (10 years). EIVFX is a more actively managed with annual turnover of: 42.00 vs. RMEBX (25.00). EIVFX has a lower initial minimum investment than RMEBX: EIVFX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 10.88 vs. EIVFX (7.25). RMEBX return over 5 years is better than : 40.75 vs. EIVFX (10.83).
EIVFXRMEBXEIVFX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years10 years-
Gain YTD3.5774.80974%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B105B1%
Annual Yield % from dividends1.051.5468%
Returns for 1 year7.2510.8867%
Returns for 3 years14.2619.1874%
Returns for 5 years10.8340.7527%
Returns for 10 years8.1463.2913%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.700.04
+6.17%
Lyell Immunopharma
AFMD1.040.02
+1.96%
Affimed NV
OMC82.30-1.30
-1.56%
Omnicom Group
APLS27.52-0.83
-2.93%
Apellis Pharmaceuticals
ROOT100.21-11.02
-9.91%
Root